Jim O'Neill
SPEAKERS
ARDD 2026
Leaders in the aging and longevity field will describe the latest progress in the molecular, cellular and organismal basis of aging and our search for interventions.
Ruth Gimeno
VP, Eli Lilly
Christophe Weber
Ex-CEO, Takeda
Elcin Barker Ergun
CEO, Menarini Group
Ariel Feldstein
CSO, Pfizer
Fiona H. Marshall
President, Novartis
Alex Zhavoronkov
CEO, Insilico Medicine
David Sinclair
Professor, Harvard Medical School
Vadim Gladyshev
Professor, Harvard Medical School
Marco Quarta
Co-Founder, Rubedo Life Sciences
Chuen Yan Leung
Investor, Value Partners Group
Laure Crabbe-Vert
Senior Life Science Innovation Manager, LVMH Research
David Furman
Professor and Director, Buck Institute for Research on Aging
Gerald Lushington
Expert Team Lead · SpaceX/Qnapsyn Biosciences, Inc.
Carl Gordon
Managing Partner, OrbiMed
Kawthar Al Ameri
Division Director of NCDs Surveillance & Screening, Abu Dhabi Public Health Center
Matthew O’Connor
CEO, Cyclarity Therapeutics
Vicky Yang
Associate Professor, Tufts University
Amol Pawar
Executive Director, UBS
Christoph Westphal
General Partner, Longwood Fund
Michael Basson
Senior Editor, Nature Medicine
Cailin McGurk
Managing Director, Morgan Stanley
Phil McGurk
SVP, Takeda
Daniel Promislow
Senior Scientist, HNRCA, Tufts University
Omar Abudayyeh
Professor, Harvard Medical School
Vishwa Deep Dixit
Professor, Yale School of Medicine
Anna Skaya
General Partner, AniVC
Tony Wyss-Coray
Professor, Stanford University
Kan Chen
Investor, Qiming Venture Partners
Adiv Johnson
CSO, Tally Health
Maximilian Unfried
Scientist, National University of Singapore
Jacqueline Lam
Scholar, University of Cambridge
Garri Zmudze
Investor, LongeVC
Jill Lee
Director, Novo Nordisk
Kirsten Seale
Scientist, TruDiagnostic
Yves Fomekong Nanfack
Head of AI/ML Research, Takeda
Debora Marks
Professor, Harvard Medical School
Alex Philippidis
Editor, Genetic Engineering & Biotechnology News
Gordan Lauc
Professor, University of Zagreb
Calum MacRae
Professor, Mass General Brigham Heart and Vascular Institute
David Dodick
CMO, The Atria Health Institute
Maria Dermit
Scientist, Novo Nordisk
Morten Scheibye-Knudsen
Professor, University of Copenhagen
Daniela Janina Bakula
Professor, University of Copenhagen
Mark Cobbold
SVP, AstraZeneca
Jim Flynn
Managing Partner, Deerfield
Murali Venkatesan
Global Head of Danaher Ventures, Danaher
James Kirkland
Professor, Robert and Arlene Kogod Center on Aging
Philipp Gut
Adult Health Lead, Nestlé Research
Christopher Austin
SVP, GSK
Yan Lei
CEO, Synaro Capital
Michael Ringel
COO, Life Biosciences
Sara Bonnes
Professor, Mayo Clinic College of Medicine
Nicole Sirotin
CEO, Institute for Healthier Living Abu Dhabi
Sebastien Thuault
Founding editor, Nature Aging
Alejandro Aguayo-Orozco
Senior Scientific Director, Novo Nordisk
Steven Quay
CEO, Atossa Therapeutics
Monika Vnuk
SVP, Sanofi
Vishnu Sresht
Director, Genentech
Claris Munksgaard
Director, EMD Serono/Merck
Björn Tackenberg
Head of Integrative Neuroscience, Roche
Barbara Cheifet
Chief Editor, Nature Biotechnology
George Church
Professor, Harvard Medical School
Evelyne Yehudit Bischof
Scientist, Sheba Longevity Center
Wei-Wu He
CEO, Human Longevity Inc.
Kaivan Khavandi
SVP, GlaxoSmithKline
Jonathan Levi
Senior Director, AstraZeneca
Xingli Wang
Global Partner, Fosun Pharma
Alfredo Viegas
Managing Director, Oaktree Capital Management
Nikolaj Roed
Global Project Leader, Novo Nordisk
Steve Horvath
Professor, University of California, Los Angeles
Gérôme Guiot
Director, LVMH
Kevin Duffin
VP, Eli Lilly
Alex Cogdill
Head of Strategic Initiatives, Daiichi Sankyo
Thomas Marron
AVP, Eli Lilly
Sophie Lemire-Brachat
Executive Director, Novartis
Morten Sogaard
SVP, Astellas
Johan Luthman
EVP, Lundbeck
Andrew Brack
Program Manager, Proactive Health · ARPA-H
Derek Huffman
Professor, Molecular Pharmacology & Medicine · Albert Einstein College of Medicine
Jonathan Weissman
Professor of Biology; Core Member, Whitehead Institute; HHMI Investigator · MIT / Whitehead Institute
Francisco Leon
Founder & CEO · Tolerance Bio
Andrew Shin
Chief Strategy Officer · Mass General Brigham
Brian Nahed
Professor & Vice Chair of Neurosurgery · Massachusetts General Hospital / Harvard Medical School
Eric Xing
President & University Professor · Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
Tala Fakhouri
Chief AI & Regulatory Strategy Officer · Parexel
Giulia Menichetti
Assistant Professor in Medicine · Harvard Medical School
Arie Belldegrun
Co-Founder · Bellco Capital
Martin Borch Jensen
Co-Founder, CSO · Gordian Biotechnology
Alexandru-Ioan Voda
CEO · The Cat Health Company
Kia Winslow
Sr. Director · BioAge
Jeffrey Siegel
Director, Office of Drug Evaluation Sciences · FDA
Justin Penzenstadler
Associate Director (Acting), OCHEN/OND/CDER · FDA
Lowell M. Zeta
Acting Chief of Staff, Office of the Commissioner · FDA
Carine Boustany
SVP, Global Head of Immunology and Respiratory Diseases · Boehringer Ingelheim
Brian Bodemann
ARTAN Bio
Brianna Stubbs
Research Assistant Professor & Director of Translational Science · Buck Institute for Research on Aging
Jonathan Gootenberg
Assistant Professor of Medicine · Harvard Medical School
George Daley
Dean of the Faculty of Medicine · Harvard Medical School
Michael Lingzhi Li
Assistant Professor of Business Administration · Harvard Business School
Anthony Philippakis
General Partner · GV
Jamie Justice
Executive Vice President, Health Domain & Executive Director, XPRIZE Healthspan · XPRIZE Foundation
Stephanie Manson-Brown
Vice President, Head of Clinical Development & Scientific Innovation and Skincare R&D · AbbVie
Elena Bonfiglioli
Global Business Leader, GM Healthcare, Pharma & Life Sciences · Microsoft
Alexander Schuchmacher
THI Business School / THI; CPI / University of St. Gallen · Germany / Switzerland
William Mair
Professor · Harvard T.H. Chan School of Public Health
Alice Park
Senior Health Correspondent · TIME
Lisa Melton
Senior News Editor · Nature Biotechnology
Patrick Temple-West
US Pharmaceutical Correspondent · Financial Times
Andrea Cipriano
Executive Committee Member, Biomarkers of Aging Consortium; Adjunct Professor, Stanford School of Medicine; Director of Immunology, Eli Lilly
Kejun Ying
Postdoctoral Scholar · Stanford University School of Medicine
Nisa Leung
Managing Partner · Aulis Capital
Eric Sun
Assistant Professor · Massachusetts Institute of Technology
Avak Kahvejian
General Partner · Flagship Pioneering
Peter Clark
VP, Computational Drug Design · Novo Nordisk
Sergey Jakimov
Founding and Managing Partner · LongeVC
Feixiong Cheng
Director, Genome Center · Cleveland Clinic
Derya Unutmaz
Professor · Jackson Laboratory for Genomic Medicine, Farmington, CT
More speakers to be announced